Enovis Revenue 2010-2024 | ENOV
Enovis revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Enovis Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $1,707 |
| 2022 | $1,563 |
| 2021 | $1,426 |
| 2020 | $1,121 |
| 2019 | $3,327 |
| 2018 | $2,193 |
| 2017 | $1,937 |
| 2016 | $3,186 |
| 2015 | $3,434 |
| 2014 | $4,624 |
| 2013 | $4,207 |
| 2012 | $3,914 |
| 2011 | $693 |
| 2010 | $542 |
| 2009 | $525 |
| Enovis Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | $505 |
| 2024-06-30 | $525 |
| 2024-03-31 | $516 |
| 2023-12-31 | $455 |
| 2023-09-30 | $418 |
| 2023-06-30 | $429 |
| 2023-03-31 | $406 |
| 2022-12-31 | $409 |
| 2022-09-30 | $384 |
| 2022-06-30 | $395 |
| 2022-03-31 | $375 |
| 2021-12-31 | $-169 |
| 2021-09-30 | $360 |
| 2021-06-30 | $356 |
| 2021-03-31 | $879 |
| 2020-12-31 | $-1,122 |
| 2020-09-30 | $806 |
| 2020-06-30 | $620 |
| 2020-03-31 | $816 |
| 2019-12-31 | $888 |
| 2019-09-30 | $847 |
| 2019-06-30 | $909 |
| 2019-03-31 | $684 |
| 2018-12-31 | $227 |
| 2018-09-30 | $524 |
| 2018-06-30 | $561 |
| 2018-03-31 | $881 |
| 2017-12-31 | $-489 |
| 2017-09-30 | $845 |
| 2017-06-30 | $848 |
| 2017-03-31 | $734 |
| 2016-12-31 | $585 |
| 2016-09-30 | $767 |
| 2016-06-30 | $957 |
| 2016-03-31 | $877 |
| 2015-12-31 | $529 |
| 2015-09-30 | $969 |
| 2015-06-30 | $1,025 |
| 2015-03-31 | $911 |
| 2014-12-31 | $1,206 |
| 2014-09-30 | $1,164 |
| 2014-06-30 | $1,199 |
| 2014-03-31 | $1,054 |
| 2013-12-31 | $1,171 |
| 2013-09-30 | $1,015 |
| 2013-06-30 | $1,074 |
| 2013-03-31 | $947 |
| 2012-12-31 | $1,027 |
| 2012-09-30 | $954 |
| 2012-06-30 | $1,046 |
| 2012-03-31 | $886 |
| 2011-12-31 | $178 |
| 2011-09-30 | $170 |
| 2011-06-30 | $187 |
| 2011-03-31 | $159 |
| 2010-12-31 | $167 |
| 2010-09-30 | $132 |
| 2010-06-30 | $123 |
| 2010-03-31 | $120 |
| 2009-12-31 | $131 |
| 2009-09-30 | $129 |
| 2009-06-30 | $129 |
| 2009-03-31 | $136 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.529B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $8.497B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.276B | 164.53 |
| Hims & Hers Health (HIMS) | United States | $5.141B | 130.72 |
| Privia Health (PRVA) | United States | $2.533B | 211.10 |
| IRhythm Technologies (IRTC) | United States | $2.362B | 0.00 |
| Azenta (AZTA) | United States | $2.001B | 99.78 |
| Omnicell (OMCL) | United States | $1.964B | 64.26 |
| Clover Health Investments (CLOV) | United States | $1.644B | 0.00 |
| 10x Genomics (TXG) | United States | $1.643B | 0.00 |
| Schrodinger (SDGR) | United States | $1.378B | 0.00 |
| Phreesia (PHR) | United States | $1.072B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.650B | 0.00 |
| Standard BioTools (LAB) | United States | $0.562B | 0.00 |
| Talkspace (TALK) | United States | $0.522B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.520B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.483B | 83.60 |
| Health Catalyst (HCAT) | United States | $0.459B | 0.00 |
| TruBridge (TBRG) | United States | $0.244B | 71.22 |
| Pulmonx (LUNG) | United States | $0.237B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.214B | 0.00 |
| American Well (AMWL) | United States | $0.122B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.107B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| HeartBeam (BEAT) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.053B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | China | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
| Outset Medical (OM) | United States | $0.039B | 0.00 |
| Movano (MOVE) | United States | $0.020B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.012B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |